Archive for the ‘researches 3’ Category
Saturday, March 29th, 2008
The Edmonton Symptom Assessment System: a 15-year retrospective review of validation studies (1991-2006).
INTRODUCTION: The purpose of this review was to identify and critique validation studies focusing on the Edmonton Symptom Assessment System (ESAS), a commonly used symptom assessment tool for advanced cancer and palliative patients. ...
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
Improving the effectiveness of interventions in palliative care: the potential role of qualitative research in enhancing evidence from randomized controlled trials.
Evaluating interventions in palliative care using randomized controlled trials (RCTs) has helped advance the specialty and create an evidence base for the delivery of care. ...
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
Palliative care: careless use of language undermines our identity.
Hanks G.
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
Therapeutic potential (1).
Zack DJ, Isenberg D.
Amgen, Thousand Oaks, California, USA.
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
Therapeutic potential (2).
Silverman G, Linnik M.
UCSD Rheumatic Diseases Core Center, UCSD School of Medicine, La Jolla, California, USA.
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
Antibodies and other biomarkers - pathological consequences (2).
Ehrenstein M, Alves J.
Centre for Rheumatology Research, Windeyer Institute of Medical Science, University College London, London, UK.
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
Pathogenic factors for the development of lupus nephritis.
Mason Lj, Berden J.
Department of Medicine, Centre for Rheumatology Research, University College London, London, UK.
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
Autoantibodies and other biomarkers - pathological consequences (1).
Giles I, Putterman C.
University College London, London, UK.
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
Signalling defects and cellular interactions (2).
Datta S, Mauri C.
Division of Rheumatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Ilinois, USA.
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
Cellular interactions and signalling defects in lupus (1).
Zouali M, Mageed R.
Inserm U606 and University of Paris Diderot-Paris, Paris, France.
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
Origin and structure of autoantibodies and antigens in autoimmune rheumatic diseases.
Rahman A, Stollar B.
Division of Medicine, Centre for Rheumatology, University College London, London, UK.
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
Successful use of rituximab in acquired C1 inhibitor deficiency secondary to Sjogren\'s syndrome.
Sánchez-Cano D, Callejas-Rubio J, Lara-Jiménez M, López-Trascasa M, Circadi M, Ortego-Centeno N.
Hospital Universitario San Cecilio, Unidad de Enfermedades Autoinmunes Sistémicas, Granada, Spain.
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
Introduction to a systemic lupus erythematosus - biomarkers meeting held at University College London on 23rd and 24th February 2007.
Isenberg D, Ehrenstein M, Rahman A.
Department of Medicine, Centre for Rheumatology, University College London, London, UK.
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
Systemic lupus erythematosus in the Fars Province of Iran.
Abstract Clinical features of systemic lupus erythematosus (SLE) have been described from different geographical regions in the world. However, data from many Middle East countries, including Iran, are scarce. This study aims to demonstrate the demographic, clinical, ...
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
Hypothyroidism determines the clinical and immunological manifestations of Arabs with lupus.
Abstract Data on thyroid disease in Arabs with lupus is scarce. We conducted a cross-sectional and retrospective case-control study to report the prevalence of thyroid diseases in 110 Arabs with lupus who attended our Rheumatology ...
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
Severe digital ischemia-a presenting symptom of malignancy-associated antiphospholipid syndrome.
The association of the antiphospholipid syndrome with malignancy has been extensively reported. Raynaud\'s phenomenon has also been reported to be associated with various malignancies. In this report, we describe two patients who presented with severe digital ischemia ...
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus.
Abstract Amegakaryocytic thrombocytopenia is an extremely rare disorder in systemic lupus erythematosus, and its mechanism and treatment are still largely unknown. We describe a 42-year-old woman with systemic lupus erythematosus ...
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
Sulpha allergy in lupus patients: a clinical perspective.
Abstract Systemic lupus erythematosus is a chronic, relapsing autoimmune disease that can affect multiple organ systems. An increased prevalence of drug allergy has been reported in lupus patients compared with the general population. Using a cohort of 417 ...
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome?
Abstract A premature atherosclerosis has been presumed in patients with antiphospholipid syndrome. The potential role of antiphospholipid antibodies in the development of atheroma is rather controversial. In this study, we ...
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
E/E\' ratio is more sensitive than E/A ratio for detection of left ventricular diastolic dysfunction in systemic lupus erythematosus.
Abstract To investigate whether the ratio of mitral peak velocity of early filling (E) to early diastolic mitral annular velocity (E\') (E/E\' ratio) can detect left ventricular ...
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
Time to seizure occurrence and damage in PROFILE, a multi-ethnic systemic lupus erythematosus cohort.
Abstract The objective of this study was to determine risk factors predicting seizures and damage caused by seizures in a multi-ethnic systemic lupus erythematosus cohort (PROFILE) that includes systemic lupus erythematosus patients ...
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
Lupus: improving long-term prognosis.
AbstractOver recent decades short- and medium-term survival has greatly improved in patients affected with systemic lupus erythematosus, but long-term prognosis still remains poor mainly due to complications of the disease and/or its treatment. To improve long-term prognosis in systemic lupus erythematosus, we ...
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease.
Autoantibodies against dense fine speckles 70 (DFS70) are found in 10% of healthy individuals, but only in a tiny population of patients with autoimmune rheumatic disease. The antibody may thus be a ...
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
Viruses and lupus: the viral hypothesis.
Ramos-Casals M.
Laboratory of Autoimmune Diseases \"Josep Font\" Hospital ClÃnic, Barcelona, Spain.
Posted in researches 3 | No Comments »
Saturday, March 29th, 2008
Measurement of central venous pressure from a peripheral intravenous catheter following cardiopulmonary bypass in infants and children with congenital heart disease.
The current study evaluates the feasibility and accuracy of measuring central venous pressure from a peripheral intravenous catheter following cardiopulmonary bypass in infants and children. ...
Posted in researches 3 | No Comments »